Item 5. Market for Registrant’s Common Equity
Item
5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.
Market
Information
Our
Common Stock is quoted under the ticker symbol “PPCB” on the Nasdaq Capital Markets, Inc. (“Nasdaq”)
On
September 18, 2026, the last reported sales price per share of our Common Stock on Nasdaq was $0.62.
Security
Holders
As
of September 23, 2026 we had 103 record holders of our Common Stock.
Dividends
We
have not paid any cash dividends to our stockholders. The declaration of any future cash dividends is at the discretion of our Board
and depends upon our earnings, if any, our capital requirements and financial position, and general economic conditions. It is our present
intention not to pay any cash dividends in the foreseeable future, but rather to reinvest earnings, if any, in our business operations.
Recent
Sales of Unregistered Securities
Issuance
of Shares of Common Stock upon Conversion of Convertible Debt
In
June 2026, the Company issued an aggregate of 67,832 shares of its common stock at an average contractual conversion price of approximately
$0.90 as a result of the conversion of principal of $55,000, interest of $5,043 and conversion fees $937 underlying certain outstanding
convertible notes converted during such period.
Issuance
of Shares of Common Stock upon Settlement
On
June 30, 2026, the Company entered into a settlement agreement and release with an investor for restricted shares of common stock and
a cash payment in exchange for a complete release of any and all potential claims, As of June 30, 2026, the Company recorded common stock
issuable of 51,289 shares. In July 2026, the Company issued 51,289 shares of the Company’s common stock valued at $75,000.
Except
as otherwise noted, the securities in the transactions described above were sold in reliance on the exemption from registration provided
in Section 4(a)(2) of the Securities Act for transactions not involving any public offering. Each of the persons acquiring the foregoing
securities was an accredited investor (as defined in Rule 501(a) of Regulation D) and confirmed the foregoing and acknowledged, in writing,
that the securities must be acquired and held for investment. All certificates evidencing the shares sold bore a restrictive legend.
No underwriter participated in the offer and sale of these securities, and no commission or other remuneration was paid or given directly
or indirectly in connection therewith. The proceeds from these sales were used for general corporate purposes.
28
Item
6. [Reserved]
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.